Network analysis useful in real-world applications for practitioners, study finds
A network survey among agencies that address cancer risk in rural Missouri and Illinois, conducted by the Brown School and the School of Medicine’s Implementation Science Center for Cancer Control, was found to be useful in helping those practitioners identify gaps, plan for how to establish future relationships and strengthen collaboration.
Investigational drug attacks synovial sarcoma, a rare type of tumor
A new study from Washington University School of Medicine describes a potential new therapy for synovial sarcoma, a rare tumor of soft tissues.
Smoking-cessation program that targets cancer patients effective
Researchers at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine have found a way to help more patients who want to stop smoking. The successful strategy involves using electronic medical records to help identify smokers when they visit their oncologists and offering help with quitting during such visits.
Patients want AI, doctors to work together
Interdisciplinary Washington University research finds patients may be OK with artificial intelligence playing a role in medical diagnostics.
Novel treatment makes pancreatic cancer susceptible to immunotherapy, mouse study shows
New research from Washington University School of Medicine shows that blocking a major inflammatory pathway in pancreatic cancer makes the tumors sensitive to chemotherapy and a type of immunotherapy that helps the immune system’s T cells to attack cancer cells.
Low-cost, 3D printed device may broaden focused ultrasound use
WashU’s Hong Chen and her team have developed a method for producing a low-cost, easy-to-use focused ultrasound device that can help open up the blood-brain barrier for non-invasive procedures and diagnostics.
Drug mimics beneficial effects of fasting in mice
An investigational cancer drug that starves tumors of their energy supply also shows evidence of improving whole body metabolism, according to a new study in mice from Washington University School of Medicine.
Boosting T cells improves survival in mice with glioblastoma
A new study from Washington University School of Medicine shows that treatment with an immune-boosting protein called interleukin 7 (IL-7) in combination with radiation improves survival in mice with glioblastoma.
Cancer Navigation
Charting the Path Forward for Low Income Women of Color
Cancer Navigation: Charting the Path Forward for Low Income Women of Color is a practical quick-reference resource for U.S. health care providers working with marginalized women throughout the cancer continuum.
New treatment target ID’d for radiation-resistant cervical cancer
Two new studies from Washington University School of Medicine have identified a previously unrecognized pathway of cell death — named lysoptosis — and demonstrate how it could lead to new therapies for cervical cancer.
Older Stories